| Financial Year |
March 31 2023 |
| Monetary Funds |
1,078,647,868.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
253,907,990.94 |
| Accounts Receivable |
232,430,894.96 |
| Advances to Suppliers |
14,732,701.21 |
| Other Receivables |
88,316.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
68,753,699.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,390,448.99 |
| Total Current Assets |
1,696,659,517.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
113,643,990.33 |
| Investment Properties |
5,257,048.36 |
| Fixed Assetes |
825,006,323.72 |
| Under-construction Projects |
15,244,289.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
109,375,212.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,990,738.67 |
| Other Non-Current Assets |
20,896,059.32 |
| Sub-Total of Non-Current Assets |
1,166,861,949.61 |
| Total Assets |
2,863,521,467.03 |
| Short-Term Loans |
472,437,424.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
202,089,397.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,749,281.08 |
| Taxes Payable |
18,044,556.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,067,309.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
134,325.94 |
| Other Current Liabilities |
47,352,495.71 |
| Sub-Total of Current Liabilities |
766,021,269.58 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
27,855,932.46 |
| Total Liabilities |
793,877,202.04 |
| Paid-In Capital(Or Share Stock) |
278,431,276.00 |
| Capital Surplus |
567,435,687.47 |
| Surplus Reserve |
139,215,638.00 |
| LESS:Treasury Stock |
104,924,207.28 |
| Undistributed Profits |
1,189,092,338.77 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,069,644,264.99 |
| Owner's Equity（Stockholder's Equity） |
2,069,644,264.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,863,521,467.03 |
